We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LYG icon
12276
CALL
Lloyds Banking Group
LYG
$72.8B
$142K ﹤0.01%
25,300
-12,900
-34% -$77.3K
2024 Q2
9 quarters
SAFE icon
12277
CALL
Safehold
SAFE
$674M
$142K ﹤0.01%
12,100
-6,200
-34% -$94.3K
2021 Q1
22 quarters
TEO icon
12278
CALL
Telecom Argentina
TEO
$4.43B
$142K ﹤0.01%
11,600
-2,900
-20% -$38.9K
2026 Q2
1 quarter
ALDX icon
12279
CALL
Aldeyra Therapeutics
ALDX
$41M
$142K ﹤0.01%
115,700
-1,900
-2% -$3.03K
2018 Q3
32 quarters
LBTYK icon
12280
CALL
Liberty Global Class C
LBTYK
$3.44B
$142K ﹤0.01%
16,000
-80,900
-83% -$821K
2026 Q1
2 quarters
BCHT icon
12281
Birchtech
BCHT
$30.8M
$142K ﹤0.01%
+101,599
New +$154K
2026 Q3
0 quarters
BCIC icon
12282
BCP Investment
BCIC
$64.6M
$142K ﹤0.01%
20,941
-5,842
-22% -$42.8K
2025 Q4
3 quarters
TOUR icon
12283
PUT
Tuniu
TOUR
$49.9M
$142K ﹤0.01%
28,600
-76,900
-73% -$387K
2026 Q2
1 quarter
BEBE icon
12284
TGE Value Creative Solutions
BEBE
$142K ﹤0.01%
14,152
-2,706
-16% -$27.1K
2026 Q2
1 quarter
DHF icon
12285
BNY Mellon High Yield Strategies Fund
DHF
$161M
$142K ﹤0.01%
63,933
+42,356
+196% +$100K
2024 Q4
7 quarters
FTLF icon
12286
FitLife Brands
FTLF
$63.4M
$142K ﹤0.01%
15,261
-2,744
-15% -$27.7K
2026 Q2
1 quarter
CSIQ icon
12287
Canadian Solar
CSIQ
$623M
$142K ﹤0.01%
12,304
-8,295
-40% -$116K
2025 Q3
4 quarters
RANI icon
12288
Rani Therapeutics
RANI
$62.8M
$142K ﹤0.01%
179,167
+121,377
+210% +$96.8K
2025 Q4
3 quarters
CODA icon
12289
Coda Octopus Group
CODA
$94.8M
$142K ﹤0.01%
+13,207
New +$135K
2026 Q3
0 quarters
MFIN icon
12290
Medallion Financial
MFIN
$211M
$142K ﹤0.01%
+11,913
New +$132K
2026 Q3
0 quarters
HPF icon
12291
John Hancock Preferred Income Fund II
HPF
$272M
$141K ﹤0.01%
+10,501
New +$162K
2026 Q3
0 quarters
CSCS icon
12292
Direxion Daily CSCO Bear 1X ETF
CSCS
$2.36M
$141K ﹤0.01%
10,056
-2,684
-21% -$36.6K
2026 Q2
1 quarter
SNDL icon
12293
CALL
Sundial Growers
SNDL
$328M
$141K ﹤0.01%
109,500
-40,800
-27% -$53.8K
2019 Q3
28 quarters
IMDX icon
12294
CALL
Insight Molecular Diagnostics
IMDX
$60.5M
$141K ﹤0.01%
+39,200
New +$174K
2026 Q3
0 quarters
GALT icon
12295
CALL
Galectin Therapeutics
GALT
$306M
$140K ﹤0.01%
36,200
-114,800
-76% -$444K
2016 Q1
42 quarters
BEAGU icon
12296
Bold Eagle Acquisition Corp Units
BEAGU
$140K ﹤0.01%
12,850
-393
-3% -$4.35K
2025 Q2
5 quarters
TRTX icon
12297
TPG RE Finance Trust
TRTX
$498M
$140K ﹤0.01%
22,370
+11,816
+112% +$93K
2025 Q4
3 quarters
CION icon
12298
CALL
CION Investment
CION
$295M
$140K ﹤0.01%
+19,900
New +$137K
2026 Q3
0 quarters
ACIU icon
12299
AC Immune
ACIU
$207M
$140K ﹤0.01%
53,305
-64
-0.1% -$162
2025 Q3
4 quarters
EFR icon
12300
Eaton Vance Senior Floating-Rate Fund
EFR
$298M
$139K ﹤0.01%
+13,409
New +$141K
2026 Q3
0 quarters

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.